These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 17189095

  • 1. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin.
    Pantopoulou A, Giamarellos-Bourboulis EJ, Raftogannis M, Tsaganos T, Dontas I, Koutoukas P, Baziaka F, Giamarellou H, Perrea D.
    Int J Antimicrob Agents; 2007 Jan; 29(1):51-5. PubMed ID: 17189095
    [Abstract] [Full Text] [Related]

  • 2. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, Belabbes H, Benbachir M.
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY, Cheong HJ, Lee J, Sung AK, Kim WJ.
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [Abstract] [Full Text] [Related]

  • 4. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M, Repetto E, Righi E, Boni S, Diverio M, Molinari MP, Mussap M, Artioli S, Ansaldi F, Durando P, Orengo G, Bobbio Pallavicini F, Viscoli C.
    J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A, Ariza J, Corbella X, Doménech A, Cabellos C, Ayats J, Tubau F, Borraz C, Gudiol F.
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [Abstract] [Full Text] [Related]

  • 6. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M, Pujol M, Tubau F, Peña C, Montero A, Domínguez MA, Gudiol F, Ariza J.
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [Abstract] [Full Text] [Related]

  • 7. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
    Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R.
    Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
    [Abstract] [Full Text] [Related]

  • 8. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
    Motaouakkil S, Charra B, Hachimi A, Benslama A.
    Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E, Sunbul M, Aksoy A, Yilmaz H, Guney AK, Guvenc T.
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [Abstract] [Full Text] [Related]

  • 10. Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report.
    Biancofiore G, Tascini C, Bisà M, Gemignani G, Bindi ML, Leonildi A, Giannotti G, Menichetti F.
    Minerva Anestesiol; 2007 Mar; 73(3):181-5. PubMed ID: 17159765
    [Abstract] [Full Text] [Related]

  • 11. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C.
    Clin Infect Dis; 2007 Sep 01; 45(5):594-8. PubMed ID: 17682994
    [Abstract] [Full Text] [Related]

  • 12. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
    Pachón-Ibáñez ME, Fernández-Cuenca F, Docobo-Pérez F, Pachón J, Pascual A.
    J Antimicrob Chemother; 2006 Sep 01; 58(3):689-92. PubMed ID: 16870647
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V.
    Int J Infect Dis; 2007 Sep 01; 11(5):402-6. PubMed ID: 17291803
    [Abstract] [Full Text] [Related]

  • 14. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY, Lee J, Heo JY, Noh JY, Kim WJ, Cheong HJ, Hwang IS.
    Int J Antimicrob Agents; 2008 Sep 01; 32(3):281-4. PubMed ID: 18650070
    [No Abstract] [Full Text] [Related]

  • 15. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
    Ho YH, Wang LS, Chao HJ, Chang KC, Su CF.
    J Microbiol Immunol Infect; 2007 Dec 01; 40(6):537-40. PubMed ID: 18087636
    [Abstract] [Full Text] [Related]

  • 16. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A, Douka E, Kriaras I, Stravopodis G, Saroglou G, Geroulanos S.
    Eur J Cardiothorac Surg; 2008 Jun 01; 33(6):1086-90. PubMed ID: 18339553
    [Abstract] [Full Text] [Related]

  • 17. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
    Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W, Chelly H, Hamida CB, Rekik N, Hammami A, Bouaziz M.
    Int J Antimicrob Agents; 2006 Oct 01; 28(4):366-9. PubMed ID: 16971093
    [Abstract] [Full Text] [Related]

  • 18. Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis.
    Rodríguez-Hernández MJ, Jiménez-Mejias ME, Pichardo C, Cuberos L, García-Curiel A, Pachón J.
    Clin Microbiol Infect; 2004 Jun 01; 10(6):581-4. PubMed ID: 15191391
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.